Biostate AI, Inc
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2025 | $4 M | No. 2 | $2 to $10 million | equity | SEC | |
| Aug 2023 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Biostate AI, Inc reported revenue of $565,452 for its most recent fiscal year (filed Jul 2026), up from $66,700 the year before.
SEC Form C/A · Jul 2026
The direct cost of what it sold was $690,981, so -22% of its revenue was left after those costs.
SEC Form C/A · Jul 2026
Net loss for the same year: $9.88 million.
SEC Form C/A · Jul 2026
Biostate AI, Inc chose not to state its revenue in its newest notice of a funding round (May 2025).
SEC Form D · May 2025
The industry group it chose in its notices: Other.
SEC Form D · May 2025
In its own words
How the company describes itself to search engines on its website, word for word.
“Biostate AI connects samples, data, and decisions to redefine precision health.”
Source: The company's website · as of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of Biostate AI, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Ashwin Gopinath | Executive officer | May 2025 |
| David Zhang | Executive officer | May 2025 |
| Eva Miao | Executive officer | May 2025 |
| Ashwin Y. Gopinath | Executive officer | Aug 2023 |
| David Y. Zhang | Executive officer | Aug 2023 |
| Eva Y. Miao | Executive officer | Aug 2023 |
| Ashwin Gopinath | Director | May 2025 |
| David Zhang | Director | May 2025 |
| Ashwin Y. Gopinath | Director | Aug 2023 |
| David Y. Zhang | Director | Aug 2023 |